Share this post:
Case Studies
Visibility and market recognition for a biopharma company
After raising 12M€, Bioxodes SA, a biopharmaceutical company specializing in the development of novel therapies for the prevention and treatment of thrombotic and inflammatory disease, wished to increase its visibility and gain market recognition. It also took advantage of this opportunity to announce the enrolment of the first patient in its phase IIa clinical trial.
To download documents, you can right-click on the links above and chose « Save link as… »